INVESTMENT ADVISORY SERVICES INC /TX /ADV
Position in LLY — ELI LILLY & Co
CIK 925953
THE WOODLANDS, TX
Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$355,031
+$85,539 QoQ
Shares Held
296
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#4,031
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INVESTMENT ADVISORY SERVICES INC /TX /ADV holds $16,555,030 across 7 Drug Manufacturers - General names. LLY ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,036 | $6,612,362 | |
| 2 | ABBV |
AbbVie Inc.
|
24,722 | $6,221,044 | |
| 3 | AMGN |
Amgen Inc
|
5,246 | $1,899,681 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,465 | $959,252 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
296 | $355,031 | |
| 6 | PFE |
Pfizer Inc
|
12,058 | $290,356 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,720 | $217,304 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $355,031 | 296 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $269,492 | 293 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $318,105 | 296 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $225,848 | 296 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $258,803 | 332 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $265,943 | 322 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $248,584 | 322 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $264,010 | 298 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $259,844 | 287 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $204,603 | 263 | Shares | Sole | 2024-04-25 | |
| No filing history on record for this holder in this stock. | ||||||